Fennec Pharmaceuticals Inc. (FENC) stock
FENCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3088% above fair value
$13.58+0.82 (+6.43%)
Close on Nov 17, 2026Market cap $476.21MP/E –Yield –
Fennec Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Fennec Pharmaceuticals's market cap was $372.76M on Nov 11, 2026, against $229.83M a year earlier. Over the last 5 years it ranged from $114.43M to $432.67M, with a median of $219.32M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $372.76M | +72.5% |
| 2025 | Dec 31, 2025 | $216.08M | +24.7% |
| 2024 | Dec 31, 2024 | $173.31M | -42.0% |
| 2023 | Dec 29, 2023 | $298.84M | +18.6% |
| 2022 | Dec 30, 2022 | $251.88M | +120.1% |
| 2021 | Dec 31, 2021 | $114.43M | -40.5% |
| 2020 | Dec 31, 2020 | $192.28M | +48.9% |
| 2019 | Dec 31, 2019 | $129.13M | +7.7% |
| 2018 | Dec 31, 2018 | $119.91M | -24.5% |
| 2017 | Dec 29, 2017 | $158.89M | +544481.6% |
| 2016 | Dec 30, 2016 | $29.18K | – |
See a number that looks wrong?